
Keywords: PD; Parkinson's disease; MPP+; 1-methyl-4-phenylpyridinium ion; DAT; dopamine transporter; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SNpc; substantia nigra pars compacta; DOPAC; 3,4-dihydroxyphenylacetate; HVA; homovanillic acid; ODEs; ordinary